Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
BIOSPECIFICS TECHNOLOGIES CORP (BSTC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/19/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/10/2019 |
4/A
| Wegman Mark N (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 1,890 shares
@ $0 |
|
| 08/29/2018 |
4/A
| Gitman Paul (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 10,000 shares
@ $50.1144, valued at
$501.1k
Sold 5,000 shares
@ $48.8831, valued at
$244.4k
Sold 4,000 shares
@ $49.7946, valued at
$199.2k
|
|
| 08/29/2018 |
4/A
| Gitman Paul (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 5,425 shares
@ $51.2748, valued at
$278.2k
Sold 6,400 shares
@ $51.0878, valued at
$327k
|
|
| 02/03/2017 |
4/A
| Wegman Thomas (President) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP |
| 02/03/2017 |
4/A
| Wegman Thomas (President) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP |
| 06/22/2015 |
4/A
| Chao Jennifer M (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 15,000 options to buy
@ $0 |
|
| 06/22/2015 |
4/A
| Mattila Jyrki (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP |
| 05/04/2015 |
4/A
| Wegman Thomas (President and Chief Executive) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 27,700 shares
@ $39.0771, valued at
$1.1M
Sold 4,300 shares
@ $39.0364, valued at
$167.9k
Sold 8,000 shares
@ $38.5, valued at
$308k
|
|
| 05/04/2015 |
4/A
| Wegman Toby (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 2,950 shares
@ $39.39, valued at
$116.2k
|
|
| 03/22/2011 |
4/A
| Gitman Paul (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Exercised 5,425 options to buy
@ $1, valued at
$5.4k
|
|
| 05/05/2010 |
4/A
| Gitman Paul (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Sold 4,000 shares
@ $25.304, valued at
$101.2k
Sold 1,000 shares
@ $26.999, valued at
$27k
Sold 5,000 shares
@ $27.654, valued at
$138.3k
Sold 5,000 shares
@ $27.469, valued at
$137.3k
Sold 5,000 shares
@ $26.999, valued at
$135k
Sold 2,020 shares
@ $25.4, valued at
$51.3k
Sold 5,480 shares
@ $26.718, valued at
$146.4k
Exercised 4,000 options to buy
@ $2.563, valued at
$10.3k
Exercised 6,000 options to buy
@ $2.563, valued at
$15.4k
Exercised 5,000 options to buy
@ $1, valued at
$5k
Exercised 5,000 options to buy
@ $1, valued at
$5k
|
|
| 01/20/2010 |
4/A
| Schamroth Michael (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 15,000 options to buy
@ $26.43, valued at
$396.5k
|
|
|
|